Blizard Jeffrey reported TELA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002012926-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 20, 2026

Published

Feb 24, 2026

Ingested by INSIDER

Nov 5, 04:15 UTC

Last re-read

Nov 5, 04:15 UTC

Extracted facts

Filer

Blizard Jeffrey

Role

President

Transaction

Grant or awardAs filed: “A”

Asset

TELA Bio, Inc. — Stock Option (Right to Buy)

Ticker

TELA

Shares

127.0K

Price per share

$0

Execution date (reported)

Feb 20, 2026

Owned after transaction

127.0K shares

Days from execution to publication

4

What this establishes

Blizard Jeffrey filed this Form 4 reporting a grant or award of TELA on Feb 20, 2026. It became public on Feb 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

President

Blizard Jeffreycik:0002012926

Issuer

TELA Bio, Inc.cik:0001561921

Revision history · 0

No field has changed since this record was first ingested.